2024. Expected Spesolimab Plasma Exposure following Intravenous and Subcutaneous Dosing in Patients with Generalized Pustular Psoriasis. SKIN The Journal of Cutaneous Medicine. 8, 2 (Mar. 2024), s359. DOI:https://doi.org/10.25251/skin.8.supp.359.